发布求助
文献互助 智能选刊 最新文献

Im Fokus Onkologie最新文献

筛选
英文 中文
Pankreaskarzinom: Verlängertes Überleben unter NALIRIFOX 胰腺癌：NALIRIFOX可延长生存期
Im Fokus Onkologie Pub Date : 2024-04-01 DOI: 10.1007/s15015-024-3763-z
T. Müller
{"title":"Pankreaskarzinom: Verlängertes Überleben unter NALIRIFOX","authors":"T. Müller","doi":"10.1007/s15015-024-3763-z","DOIUrl":"https://doi.org/10.1007/s15015-024-3763-z","url":null,"abstract":"","PeriodicalId":13436,"journal":{"name":"Im Fokus Onkologie","volume":"273 ","pages":"36"},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140755587","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mangelernährung ist auch bei Übergewicht möglich 如果体重超重，也有可能营养不良
Im Fokus Onkologie Pub Date : 2024-04-01 DOI: 10.1007/s15015-024-3799-0
Miriam Sonnet
{"title":"Mangelernährung ist auch bei Übergewicht möglich","authors":"Miriam Sonnet","doi":"10.1007/s15015-024-3799-0","DOIUrl":"https://doi.org/10.1007/s15015-024-3799-0","url":null,"abstract":"","PeriodicalId":13436,"journal":{"name":"Im Fokus Onkologie","volume":"81 10","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140758985","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Wann sich BRCA-Testen lohnt 何时值得进行 BRCA 检测
Im Fokus Onkologie Pub Date : 2024-04-01 DOI: 10.1007/s15015-024-3793-6
T. Müller
{"title":"Wann sich BRCA-Testen lohnt","authors":"T. Müller","doi":"10.1007/s15015-024-3793-6","DOIUrl":"https://doi.org/10.1007/s15015-024-3793-6","url":null,"abstract":"","PeriodicalId":13436,"journal":{"name":"Im Fokus Onkologie","volume":"822 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140776928","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Empfehlungen der AGO-Kommission Mamma 2024 - was ist neu? AGO 委员会关于《2024 年乳业》的建议--有哪些新内容？
Im Fokus Onkologie Pub Date : 2024-04-01 DOI: 10.1007/s15015-024-3820-7
Petra Ortner
{"title":"Empfehlungen der AGO-Kommission Mamma 2024 - was ist neu?","authors":"Petra Ortner","doi":"10.1007/s15015-024-3820-7","DOIUrl":"https://doi.org/10.1007/s15015-024-3820-7","url":null,"abstract":"","PeriodicalId":13436,"journal":{"name":"Im Fokus Onkologie","volume":"122 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140780388","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
RCC: Länger progressionsfrei mit Cabozantinib RCC：使用卡博替尼可获得更长的无进展时间
Im Fokus Onkologie Pub Date : 2024-04-01 DOI: 10.1007/s15015-024-3807-4
Redaktion Facharztmagazine
{"title":"RCC: Länger progressionsfrei mit Cabozantinib","authors":"Redaktion Facharztmagazine","doi":"10.1007/s15015-024-3807-4","DOIUrl":"https://doi.org/10.1007/s15015-024-3807-4","url":null,"abstract":"","PeriodicalId":13436,"journal":{"name":"Im Fokus Onkologie","volume":"27 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140797522","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
TNBC: Toripalimab plus nab-Paclitaxel verzögert die Progression TNBC：托利帕单抗联合纳布-紫杉醇抑制病情恶化
Im Fokus Onkologie Pub Date : 2024-04-01 DOI: 10.1007/s15015-024-3790-9
Robert Bublak
{"title":"TNBC: Toripalimab plus nab-Paclitaxel verzögert die Progression","authors":"Robert Bublak","doi":"10.1007/s15015-024-3790-9","DOIUrl":"https://doi.org/10.1007/s15015-024-3790-9","url":null,"abstract":"","PeriodicalId":13436,"journal":{"name":"Im Fokus Onkologie","volume":"76 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140790375","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sport hilft bei Chemotherapie-induzierter Neuropathie 运动有助于缓解化疗引起的神经病变
Im Fokus Onkologie Pub Date : 2024-04-01 DOI: 10.1007/s15015-024-3771-z
Oliver Növermann, J. Neumaier
{"title":"Sport hilft bei Chemotherapie-induzierter Neuropathie","authors":"Oliver Növermann, J. Neumaier","doi":"10.1007/s15015-024-3771-z","DOIUrl":"https://doi.org/10.1007/s15015-024-3771-z","url":null,"abstract":"","PeriodicalId":13436,"journal":{"name":"Im Fokus Onkologie","volume":"23 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140783344","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CAR-T-Zell-Therapie beim multiplen Myelom früher erwägen? 更早地考虑使用 CAR T 细胞疗法治疗多发性骨髓瘤？
Im Fokus Onkologie Pub Date : 2024-04-01 DOI: 10.1007/s15015-024-3758-9
E. Oberhofer
{"title":"CAR-T-Zell-Therapie beim multiplen Myelom früher erwägen?","authors":"E. Oberhofer","doi":"10.1007/s15015-024-3758-9","DOIUrl":"https://doi.org/10.1007/s15015-024-3758-9","url":null,"abstract":"","PeriodicalId":13436,"journal":{"name":"Im Fokus Onkologie","volume":"306 1","pages":"59"},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140779390","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Eltrombopag bei Niedrig-Risiko-MDS mit Thrombozytopenie wirksam 艾曲波帕对伴有血小板减少的低风险 MDS 有效
Im Fokus Onkologie Pub Date : 2024-04-01 DOI: 10.1007/s15015-024-3769-6
F. Klein
{"title":"Eltrombopag bei Niedrig-Risiko-MDS mit Thrombozytopenie wirksam","authors":"F. Klein","doi":"10.1007/s15015-024-3769-6","DOIUrl":"https://doi.org/10.1007/s15015-024-3769-6","url":null,"abstract":"","PeriodicalId":13436,"journal":{"name":"Im Fokus Onkologie","volume":"58 43","pages":"61"},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140795422","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impfung schützt vor Rezidiv beim Hochrisiko-Melanom 疫苗接种可预防高危黑色素瘤复发
Im Fokus Onkologie Pub Date : 2024-04-01 DOI: 10.1007/s15015-024-3764-y
Kathrin von Kieseritzky
{"title":"Impfung schützt vor Rezidiv beim Hochrisiko-Melanom","authors":"Kathrin von Kieseritzky","doi":"10.1007/s15015-024-3764-y","DOIUrl":"https://doi.org/10.1007/s15015-024-3764-y","url":null,"abstract":"","PeriodicalId":13436,"journal":{"name":"Im Fokus Onkologie","volume":"124 3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140793211","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：604180095
Book学术官方微信